Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

Heterozygous Familial Hypercholesterolemia Clinical Trials

2 recruiting trials for Heterozygous Familial Hypercholesterolemia. Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
2
Total Trials
2
Recruiting Now
1
Phase 3 Trials
2
Sponsors

Recruiting Trials

RECRUITINGNCT06634160

Assessment of the Prevalence of Steatotic Liver Disease Associated With Metabolic Dysfunction in Patients With...

The main goal of the STEATO-FH study is to determine the prevalence of liver steatosis within the Heterozygous Familial Hypercholesterolemia patient population.

Sponsor: Nantes University HospitalEnrolling: 2003 locations
RECRUITINGPhase 3NCT06568471

A Study on Efficacy and Safety of HST101 in Chinese Patients with Hypercholesterolemia

This randomized study is to assess LDL-C reductions at Week 12 with monthly (Q4W \[≤31 days\]) dosing of HST101 (lerodalcibep) 300 mg administered subcutaneously (SC) compared to...

Sponsor: Hasten Biopharmaceutical Co., Ltd.Enrolling: 21018 locations